Meihua International Medical Technologies Co., Ltd.
Meihua International Medical Technologies Co., Ltd. is a medical technology company with operating roots in China and a U.S.-incorporated subsidiary used to support its cross-border expansion. Its business includes the research, development, manufacturing, and sale of disposable medical devices, alongside a newer SaaS-oriented offering for medical registration and related digital services.
Fiscal year 2025 · change from previous year
Development 2020–2025
Business
Share of revenueSingle-use medical devices manufactured and sold through the company’s China-based operations.
Software subscriptions and related digital tools for medical registration and workflow support.
Custom upgrades, consulting, and commercial empowerment services sold around the SaaS platform.
Products
Reported · share of revenue- Produced44.0 %
- Self Manufactured Products44.0 %
- Direct Sales of Disposable Medical Devices9.4 %
- Saa S Development Service2.6 %
Source: 20-F FY2025, revenue the company reports per product line (SEC XBRL). Shares are of the lines shown and add up to 100 %.
Customers
The company sells to healthcare providers, device merchants, and SaaS distributors that need medical registration, workflow, and digital management tools. Its legacy device business serves hospital and clinical end markets in China, while its newer software offering is aimed at buyers across North America, Hong Kong, and Southeast Asia. The customer base reflects a mix of physical product purchasers and recurring software buyers with compliance and operational needs.
Hospitals, clinics, and other providers that buy medical devices and SaaS tools for registration and operations
Merchants that use the platform for medical registration, product information, and workflow support
Channel partners that distribute the company’s medical SaaS systems
Smaller practices targeted for standardized cloud tools and compliance support
Strategy
The company is transitioning from a device-centric business toward a SaaS-led model that can generate subscription and value-added service revenue. Its strategy emphasizes medical registration software, remote consultation, AI tools, and commercial empowerment services to deepen customer relationships and broaden monetization. The U.S. subsidiary is intended to support cross-border commercialization and regulatory localization in target markets.
Recurring software revenue can diversify the business away from pure device sales
Custom services can increase revenue per customer and improve platform stickiness
A U.S. operating base can improve compliance and customer adoption in target markets
Geography
The company’s established manufacturing and device sales operations are based in China, where its operating subsidiaries produce disposable medical devices. It is also building a U.S.-based SaaS business through Meihua Future, with planned sales across North America, Hong Kong, and Southeast Asia. Geography matters because the SaaS model depends on local compliance, customer trust, and digital infrastructure in each target market.
Risks
The company faces execution risk as it moves into an early-stage SaaS business while maintaining its legacy medical device operations. Its results are exposed to regulatory change, technology performance issues, and adoption risk in new markets, while the device business remains sensitive to manufacturing quality, supply continuity, and healthcare demand cycles. Cross-border expansion also raises compliance, infrastructure, and cybersecurity risks.
- Early-stage SaaS commercializationImpact: HighLikelihood: High
The software business is new and still being tested commercially, so demand and retention are uncertain
Exposure - Regulatory and compliance riskImpact: HighLikelihood: Medium
Medical devices and medical software are both regulated and can face country-specific approval requirements
Exposure: China and overseas markets
- Product and system performance riskImpact: MediumLikelihood: Medium
Delays in enhancements or weak system performance could damage customer trust and limit adoption
Exposure: SaaS platform
- Operational and supply-chain disruptionImpact: MediumLikelihood: Medium
Device manufacturing depends on uninterrupted operations, quality control, and logistics
Exposure: Disposable medical devices
- Cybersecurity and infrastructure riskImpact: MediumLikelihood: Medium
Software platforms require reliable infrastructure and protection from outages or attacks
Exposure: SaaS business
Accounting
Judgemental itemsDevice sales and SaaS subscriptions likely follow different recognition patterns, affecting quarterly comparability
Impact: Reported revenue timing and deferred revenue balances
Bundled software, upgrades, and services may require judgment in assigning transaction prices
Impact: Revenue mix and margin presentation
Costs tied to platform development may be capitalized or expensed depending on technical criteria
Impact: Operating expenses and intangible assets
An early-stage SaaS initiative may require judgments on recoverability and expected losses
Impact: Asset values and earnings volatility
Similar listed companies
Publicly listed companies with a comparable business focus.
Meiwu Technology Co Ltd
WNW · Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics
Meiwu Technology Co Ltd is a British Virgin Islands holding company with operating subsidiaries in China focused on functional skincare and related health technology activities.
Mobile-health Network Solutions
MNDR · Services-Prepackaged Software
Mobile-health Network Solutions is a Singapore-headquartered digital health company that operates an AI-enabled telemedicine platform and related virtual-care software.
Longduoduo Co Ltd
LDDD · Services-Health Services
Longduoduo Co Ltd is a U.S.-listed company with operating subsidiaries in Inner Mongolia and Beijing that generates revenue from two main activities: direct…
Concord Medical Services Holdings Ltd
CCM · Services-Offices & Clinics of Doctors of Medicine
Concord Medical Services Holdings Ltd is a medical services group headquartered in Beijing, with operations centered on hospital, clinic, and other healthcare service assets in China.
Baird Medical Investment Holdings Ltd
BDMDW · Surgical & Medical Instruments & Apparatus
Baird Medical Investment Holdings Ltd is a U.S.-listed medical device company focused on minimally invasive ablation technologies for solid tumors.
Zhongchao Inc.
ZCMD · Services-Educational Services
Last updated: 28/09/2026